Vitamin K status in patients with short bowel syndrome

Clin Nutr. 2012 Dec;31(6):1015-7. doi: 10.1016/j.clnu.2012.04.014. Epub 2012 May 26.

Abstract

Background & aims: Available evidence suggests that patients with short bowel syndrome (SBS) might be at risk of vitamins A, D, E and B(1) deficiency. However, there is little clinical data describing the vitamin K status. Therefore, in the present study we aimed to assess the body resources of vitamin K in a subset of SBS patients.

Methods: The study comprised 33 patients aged 1 month to 16 years. PIVKA-II concentrations were determined in all subjects.

Results: In all studied subjects, coagulation parameters were normal. PIVKA-II levels indicative of vitamin K deficiency was found in 3 (9.1%) SBS patients. One patient had been receiving an additional intravenous vitamin K dose of 5 mg/week. In all SBS patients with cirrhosis and cholestasis, PIVKA-II concentrations were low (<2 ng/ml). However, all patients with severe liver disease were receiving vitamin K several times a month.

Conclusions: Vitamin K deficiency may appear in SBS patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antifibrinolytic Agents / administration & dosage
  • Antifibrinolytic Agents / blood*
  • Biomarkers / blood
  • Blood Coagulation
  • Child
  • Child, Preschool
  • Cholestasis / blood
  • Female
  • Humans
  • Infant
  • Liver Cirrhosis / blood
  • Male
  • Protein Precursors / blood
  • Prothrombin
  • Short Bowel Syndrome / blood*
  • Short Bowel Syndrome / complications
  • Vitamin K / administration & dosage
  • Vitamin K / blood*
  • Vitamin K Deficiency / complications
  • Vitamin K Deficiency / diagnosis*
  • Vitamins / administration & dosage
  • Vitamins / blood*

Substances

  • Antifibrinolytic Agents
  • Biomarkers
  • Protein Precursors
  • Vitamins
  • Vitamin K
  • acarboxyprothrombin
  • Prothrombin